MCCC2 and colorectal carcinoma: The patient group with higher MCCC2 expression had longer overall survival time than the group with relatively low MCCC2 expression (Fig. 5E), similar to the analysis results from the TCGA CRC cohort (Fig. 5F) and GSE41258 CRC cohort (Fig. 5G) (https://portal.gdc.cancer.gov/ and https://www.ncbi.nlm.nih.gov/geo/).